Highlights
- EPS (TTM)
- -$3.86
- Total Revenue (TTM)
- $35.90M
- Gross Profit (TTM)
- $810.00K
- EBITDA (TTM)
- -$209.52M
- Year Range
- $47.86 - $114.91
- Target Price
- $110.42
- ROA (TTM)
- -49.25%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Arcellx Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Arcellx Inc (ACLX) has returned 76.10% so far this year and 75.03% over the past 12 months.
Arcellx Inc
- 1D
- 0.04%
- 1M
- 0.91%
- YTD
- 76.10%
- 6M
- 39.85%
- 1Y
- 75.03%
- 3Y*
- 55.04%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Feb 4, 2022, ACLX's average daily return is +0.28%, while the average monthly return is +5.65%. At this rate, your investment would double in approximately 1.1 years.
Historically, 68% of months were positive and 32% were negative. The best month was Feb 2026 with a return of +66.6%, while the worst month was Jun 2023 at -28.4%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.
On a daily basis, ACLX closed higher 50% of trading days. The best single day was Feb 23, 2026 with a return of +77.4%, while the worst single day was May 6, 2025 at -18.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.77% | 66.58% | 0.91% | 76.10% | |||||||||
| 2025 | -11.16% | -4.86% | 1.20% | -0.99% | -4.45% | 6.11% | 8.41% | -2.80% | 18.32% | 9.93% | -19.43% | -10.33% | -14.98% |
| 2024 | 11.42% | 6.44% | 5.67% | -28.08% | 3.96% | 6.13% | 11.99% | 11.21% | 21.49% | 0.91% | 4.51% | -12.92% | 38.18% |
| 2023 | 7.84% | -16.16% | 10.00% | 38.53% | 3.44% | -28.38% | 8.32% | 4.64% | 0.11% | -1.76% | 49.02% | 5.65% | 79.15% |
| 2022 | 13.93% | -26.75% | -22.04% | 10.80% | 49.30% | 14.66% | -13.31% | 4.45% | 25.09% | -15.08% | 55.37% | 84.40% |
Benchmark Metrics
Arcellx Inc has an annualized alpha of 85.30%, beta of 0.88, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since February 07, 2022.
- This stock captured 150.59% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -71.99%) — a profile typical of hedging or uncorrelated assets.
- R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 85.30%
- Beta
- 0.88
- R²
- 0.04
- Upside Capture
- 150.59%
- Downside Capture
- -71.99%
Return for Risk
Risk / Return Rank
ACLX ranks 79 for risk / return — better than 79% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Arcellx Inc (ACLX) and compare them to a chosen benchmark (S&P 500 Index).
| ACLX | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.83 | 0.90 | -0.07 |
Sortino ratioReturn per unit of downside risk | 2.47 | 1.39 | +1.08 |
Omega ratioGain probability vs. loss probability | 1.37 | 1.21 | +0.16 |
Calmar ratioReturn relative to maximum drawdown | 2.09 | 1.40 | +0.69 |
Martin ratioReturn relative to average drawdown | 4.96 | 6.61 | -1.64 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore ACLX risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Arcellx Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Arcellx Inc was 62.33%, occurring on May 18, 2022. Recovery took 14 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.33% | Mar 1, 2022 | 56 | May 18, 2022 | 14 | Jun 8, 2022 | 70 |
| -50.44% | Nov 12, 2024 | 119 | May 6, 2025 | 200 | Feb 23, 2026 | 319 |
| -38.52% | Jun 13, 2022 | 4 | Jun 16, 2022 | 122 | Dec 9, 2022 | 126 |
| -33.53% | May 11, 2023 | 34 | Jun 29, 2023 | 91 | Nov 7, 2023 | 125 |
| -32.32% | Mar 21, 2024 | 36 | May 10, 2024 | 82 | Sep 9, 2024 | 118 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Arcellx Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Arcellx Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ACLX relative to other companies in the Biotechnology industry. Currently, ACLX has a P/S ratio of 180.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |